Robotic surgery for benign gynaecological disease

Area of Science:

• Minimally Invasive Surgery
• Gynecological Oncology
• Surgical Robotics

Background:

• Robotic surgery offers potential advantages in minimally invasive gynecological procedures.
• Current evidence suggests feasibility and safety in benign gynecological diseases.
• High costs and retraining needs are significant disadvantages of robotic systems.

Purpose of the Study:

• To assess the effectiveness and safety of robot-assisted surgery for benign gynecological disease.

Main Methods:

• Searched Cochrane, CENTRAL, MEDLINE, and EMBASE databases up to November 2011.
• Included randomized controlled trials (RCTs) comparing robotic, laparoscopic, or open surgery.
• Independently screened studies, assessed risk of bias, and analyzed dichotomous and continuous data.

Main Results:

• Two RCTs with 158 participants were included; limited data available from one conference proceeding.
• Robotic surgery showed comparable conversion rates to open surgery versus laparoscopy (OR 1.41, 95% CI 0.22 to 9.01).
• Robotic surgery resulted in longer operation times (MD 66.00) and higher costs (MD 1936.00) compared to laparoscopy.

Conclusions:

• Limited evidence indicates robotic surgery offers no effectiveness or safety benefits for benign gynecological disease.
• Further well-designed RCTs with complete data are necessary.
• Current findings suggest robotic surgery is not superior to conventional methods for these conditions.